Provide two different examples of how research uses hypothesis testing, and describe the criteria for rejecting the null hypothesis. Discuss why this is important in your practice and with p

A Sponsor is submitting an Oncology drug product filing in both the US and the EU markets. The expectation is that the EU specific data filing should take precedence. Which of the following applies accurately for the EU eCTD process based upon the EU eCTD Guidance?
1. The EU guidance does not apply to the electronic submission of pre-marketing authorisation (MA) information such as, example – Orphan drug designations.
2. In submission process the sequence is not required to be grouped.
3. The current EU eCTD requirements do not require specifications from M2.